Financials
- Market Capitalization 1.6 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.86
ratio cours/chiffre d'affaires
18.95
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2136 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.72 USD | +0.35% | -12.54% | -4.67% | +126.98% | 1.64 B USD | ||
| 2145 | INVA Innoviva, Inc. - Common Stock | 21.90 USD | +0.74% | -1.66% | -4.66% | +22.90% | 1.62 B USD | ||
| 2147 | ABSI Absci Corporation - Common Stock | 10.17 USD | -0.59% | -6.61% | +39.51% | +286.69% | 1.59 B USD | ||
| 2159 | SEPN Septerna, Inc. - Common Stock | 33.98 USD | -1.62% | -5.66% | -5.43% | +54.38% | 1.53 B USD |